Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amphastar Pharmaceuticals, Inc.
Age
12–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Only subjects who have successfully completed the E004-C study within the last 135 days or those who are actively enrolled in the current study E004-C at the time of the study extension initiation
Male and female asthma patients aged 12 - 75 years
Patients with documented asthma, requiring inhaled epinephrine or beta 2-agonist treatment
No significant changes in asthma therapy and no asthma-related hospitalization or emergency visits, within 4 weeks prior to Screening
Demonstrating satisfactory techniques in the use of metered-dose inhaler and a hand held peak expiratory flow meter
Female patients of child-bearing potential must be non-pregnant and non-lactating at Screening and throughout the study, and must use an acceptable method of contraception during the study
You may not be if
A smoking history of 10-pack years, or having smoked within 12 months of screening
Any current or past medical conditions that, per investigator discretion, might significantly affect responses to the study drugs, other than asthma
Concurrent clinically significant diseases
Known intolerance or hypersensitivity to any component of the study drugs
Recent infection of the respiratory tract, before screening
Use of prohibited medications
Having been on other investigational drug/device studies in the last 30 days prior to screening
